On September 26, 2017, the Board approved $8.6 million to fund a new study comparing treatment options for people with psoriasis. The Board also approved $2.75 million to support a $5 million funding opportunity in partnership with the American Heart Association (AHA) to improve the treatment of atrial fibrillation (AFib). Read more about the new study and the AHA-PCORI partnership.
All PCORI Board meetings are open to the public. This meeting was held via teleconference/webinar with no public comment period.